Research Progress on Health Benefits and Implementation Strategies of Dietary Methionine Restriction

被引:0
|
作者
Lu M. [1 ]
Qian J. [1 ]
Yang Y. [1 ]
Xie Y. [1 ]
Le G. [2 ]
机构
[1] National Engineering Research Center of Wheat and Corn Further Processing, Henan University of Technology, Zhengzhou
[2] State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi
来源
Shipin Kexue/Food Science | 2023年 / 44卷 / 11期
关键词
health benefits; implementation strategies; metabolic syndrome; methionine restriction; prolonging lifespan; tumor;
D O I
10.7506/spkx1002-6630-20220408-088
中图分类号
学科分类号
摘要
Methionine is the only essential sulfur-containing amino acid required for the human body and is involved in important metabolic pathways including protein synthesis, transsulfuration, and one-carbon metabolism. However, in recent years, a large number of studies have shown that restricting dietary methionine intake exerts many physiological functions beneficial to body health. This article comprehensively summarizes the benefits of methionine restriction (MR) including promoting gut health, prolonging lifespan, reducing lipid accumulation and body mass, increasing insulin sensitivity, ameliorating diabetes, atherosclerosis and other cardiovascular diseases, improving learning and memory function, and anti-tumor and anti-cancer effects, as well as the effects of MR on bone and skeletal muscle function and protein synthesis. In addition, the strengths and weaknesses of five MR strategies including protein-restriction diet, vegan diet, diet formulation based on monomeric amino acid, oral methioninase, and injection of recombinant methioninase are reviewed in this article. It also discusses future major research directions, which may provide a theoretical reference for the development and application of new foods containing low levels of methionine and the realization of the health functions of MR. © 2023 Chinese Chamber of Commerce. All rights reserved.
引用
收藏
页码:367 / 378
页数:11
相关论文
共 116 条
  • [111] YANG Z, WANG J, LU Q, Et al., PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates, Cancer Research, 64, 18, pp. 6673-6678, (2004)
  • [112] KAWAGUCHI K, HAN Q, LI S, Et al., Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention, Cell Cycle, 17, 3, pp. 356-361, (2018)
  • [113] TASHIRO Y, HAN Q, TAN Y, Et al., Oral recombinant methioninase prevents obesity in mice on a high-fat diet, In Vivo, 34, 2, pp. 489-494, (2020)
  • [114] HAN Q H, HOFFMAN R M., Chronic treatment of an advanced prostate-cancer patient with oral methioninase resulted in long-term stabilization of rapidly rising PSA levels, In Vivo, 35, 4, pp. 2171-2176, (2021)
  • [115] HAN Q H, TAN Y Y, HOFFMAN R M., Oral dosing of recombinant methioninase is associated with a 70% drop in PSA in a patient with bone-metastatic prostate cancer and 50% reduction in circulating methionine in a high-stage ovarian cancer patient, Anticancer Research, 40, 5, pp. 2813-2819, (2020)
  • [116] HARTMANN R, MEISEL H., Food-derived peptides with biological activity: from research to food applications, Current Opinion in Biotechnology, 18, 2, pp. 163-169, (2007)